News
Cabenuva HIV Drug From GlaxoSmithKline Gets FDA Approval
Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was regarded as a peerless...
News
In GSK Patent Settlement, Gilead To Pay $1.25B On Biktarvy
It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in HIV domain for a long time,...
Packaging & Labelling
Sensitech Launches App-Enabled, Touchless Temperature Monitoring Solution for Enhanced Supply Chain Visibility
Sensitech, a leading provider of global supply chain visibility solutions, launched the TempTale® Ultra BLE, the newest wireless addition to its industry-leading line of...
Drug Research
Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody
Biogen Inc. announced that it exercised its option to participate in the development and commercialization of mosunetuzumab. Biogen will pay a $30 million one-time...
Press Releases
Oak Hill Bio Launches with Pipeline and Senior Leadership from Takeda
Oak Hill Bio, a clinical-stage rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases, announced...
Press Releases
Zydus supplies the first consignment of its COVID-19 vaccine ZyCoV-D
Zydus announced that the company has started the supplies of its COVID-19 vaccine ZyCoV-D, to the Government of India against their order from its...
Drug Research
Antiverse collaborates with a top 20 pharma company to identify antibody drug candidates using AI Augmented Drug Discovery platform
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, announced a partnership with a top 20 pharma company with core competencies in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read